NASDAQ · Medical - Healthcare Information Services

Forian Inc (FORA) Stock

$2.17 +0.00% NASDAQ: FORA Healthcare

Forian Inc. delivers advanced software solutions, proprietary data insights, and sophisticated predictive analytics.

Valuation

MetricValue
Price$2.17
Market Cap$67.79M
P/E Ratio-24.11
P/B Ratio2.26
P/S Ratio2.26
EPS (TTM)$-0.09
52-Week High$2.71
52-Week Low$1.64
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-10.00%
ROA-6.82%
ROCE-6.67%
Gross Margin-10.00%
Operating Margin-6.67%
Net Margin-17.00%
Debt/Equity0.00
Current Ratio3.07

Annual Financials (USD)

Metric20212022202320242025
Revenue$17.0M$16.0M$20.0M$20.0M$30.0M
Operating Profit$-28.0M$-19.0M$-6.0M$-7.0M$-2.0M
Net Profit$-27.0M$-26.0M$11.0M$-4.0M$-3.0M
EPS$-0.84$-0.81$0.36$-0.12$-0.09
Op Margin-163.6%-115.4%-27.3%-34.7%-8.2%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$57.0M$46.0M$61.0M$47.0M$44.0M
Total Liabilities$32.0M$34.0M$33.0M$17.0M$14.0M
Cash$19.0M$3.0M$6.0M$5.0M$13.0M
Borrowings$25.0M$26.0M$23.0M$7.0M$0

Latest News

Skanska wins $104m Kristianstad city campus contract World Construction Network · Jul 16, 2026 Halliburton wins unconventional gas project contract from Aramco Offshore Technology · Jul 16, 2026 A Leading Global AI Hyperscaler Selects ATLANT 3D's NANOFABRICATOR® Platform for Setting AI-Driven Materials Discovery Lab PR Newswire · Jul 16, 2026 EoS Fitness Powers Through Q2 with Standout Growth Business Wire · Jul 16, 2026 Business investment per worker in Canada--a key driver of higher living standards--declined from 87.3% of U.S. level in 2014 to 54.0% in 2024 CNW Group · Jul 16, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-17.0M$-9.0M$1.0M$0$3.0M
Investing Cash Flow$-2.0M$-7.0M$7.0M$17.0M$13.0M
Financing Cash Flow$0$0$-4.0M$0$-1.0M
Net Cash Flow$18.0M$-15.0M$3.0M$-1.0M$8.0M
Free Cash Flow$-19.0M$-9.0M$1.0M$0$3.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield3.44%
Quick Ratio3.14
Interest Coverage—
Return 1Y—
Return 3Y—
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AMWL $10.87 +0.88% -1.32 $181.54M 0.00%
ASRT $23.44 +0.30% -4.95 $151.47M 0.00%
BEAT $0.50 +0.98% -1.48 $17.10M 0.00%
GEG $2.18 -0.46% 6.61 $68.36M 0.00%
LUNG $1.22 +4.27% -1.23 $51.53M 0.00%

About Forian Inc

Forian Inc. delivers advanced software solutions, proprietary data insights, and sophisticated predictive analytics. These offerings are designed to enhance the operational efficiency, clinical effectiveness, and financial stability of its diverse clientele, which spans the healthcare, cannabis, and government sectors. The company structures its operations into three primary segments: Information & Software, Services, and Other. Among its key product lines, Forian provides several critical tools for the cannabis industry. BioTrack is a comprehensive, vertically integrated software system that supports dispensaries, cultivators, manufacturers, and distributors with point-of-sale, production, and delivery management. Complementing this is Cannalytics, a Software as a Service (SaaS) analytics platform that offers clients a clear overview of their business performance. Furthermore, Forian offers robust compliance solutions like the BioTrack seed-to-sale platform, which facilitates the tracking and tracing of cannabis products from cultivation through to final sale. Its BioTrack State Traceability & Enforcement Monitoring System (STEMS) is specifically tailored for regulatory agencies, providing a module for cannabis program management and ensuring transparency and accountability across the supply chain. Beyond its core software and data offerings, Forian also extends its services to include security monitoring and web marketing. The company is based in Newtown, Pennsylvania.

Forian Inc is led by CEO Max C. Wygod, employs 47 people, headquartered in US, publicly traded since 2021.

Forian Inc (FORA) stock trades at $2.17 with a market capitalization of $67.79M. The stock is valued at a price-to-earnings (P/E) ratio of -24.11, price-to-book of 2.26, price-to-sales of 2.26. Over the past 52 weeks the stock has ranged between $1.64 and $2.71, and currently trades 19.9% below its 52-week high.

On profitability, Forian Inc generates a return on equity (ROE) of -10.00%, return on capital employed of -6.67%, an operating margin of -6.67%, a net profit margin of -17.00%.

Official website: forian.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides